Benign Prostate Hyperplasia or in the medical fieldknown as BPH is a hyperplasia of prostate gland, causing enlargement gland.1Enlargement this organ will cause blockage posterior urethra that obstructs flow urine.2 In Indonesia, occurs 50% men with urinary tract stones.3 The prevalence increase age for people over 40 years old. For aged 60 old, BHP around 70% time and 80 possibility reaches 90...

Benign prostatic hyperplasia (BPH) is a benign hyperplasia of prostate gland cells of the urethra affecting increasing population. The most common method of treatment is transurethral resection of the prostate (TURP). But many complications may occur including intraoperative or postoperative hemorrhage, prostate perforation, urinary incontinence and bladder neck contracture. Transurethral ballo...

Estrogen has important roles in the initiation and development of benign prostatic hyperplasia (BPH). Regulators of the estrogen receptor (ER) are tissue- and cell-specific. We evaluated the effect of estrogen antagonist, raloxifene (Ral), on the prevention and treatment of BPH by investigating its effect on the proliferation of two different prostate cell lines: a stromal cell line, WPMY-1, an...

androgenic alopecia as a physiologic process and benign prostatic hyperplasia (bph) as a pathologic process in the older population are androgen-dependent processes influenced by 5-alpha reductase enzyme which converts testosterone to dihydrotestosterone. this cross sectional study was done to evaluate the relationship between androgenic alopecia and bph. 150 men older than 50 years old, who pr...

Benign prostatic hyperplasia (BPH) is a prevalent disease, especially in old men, and often results in lower urinary tract symptoms (LUTS). This chronic disease has important care implications and financial risks to the health care system. LUTS are caused not only by mechanical prostatic obstruction but also by the dynamic component of obstruction. The exact etiology of BPH and its consequences...

PURPOSE The incidence of benign prostatic hyperplasia increases among obese individuals, but few studies have fully explained the underlying mechanisms. Adiponectin has drawn much attention in recent years due to its protective role in obesity-related diseases. Here we aimed to investigate the possible molecular mechanisms and clinical significance of adiponectin in relation to benign prostatic...

We have read the article by Cyrus et al. [1], which was an interesting study investigating the impact of metabolic syndrome (MetS) on the treatment of benign prostatic hyperplasia (BPH). In their study, Cyrus et al. tried to evaluate the effect of MetS on the response to combination therapy with an α-blocker and 5α-reductase inhibitor (5ARI) after a 3-month period of therapy. Although the mean ...

Objective: To determine the diagnostic accuracy of PSA density in Prostate Cancer, Benign Prostatic Hyperplasia (BPH) and Prostatitis, taking biopsy as gold standard.
 Study Design: Cross-sectional study.
 Place Duration Study: Chemical Pathology Endocrinology Department, Armed Forces Institute (AFIP) collaboration with Histopathology department, AFIP, Urology (AFIU) Radiology (AFIRI)...

background: prostatic adenocarcinoma is the most prevalent cancer and the second cause of cancer-related death among men. human papilloma virus (hpv) considered as a preventable risk factor for prostatic adenocarcinoma. in this study, we detected the frequency of hpv infection in prostatic adenocarcinoma and benign prostatic hyperplasia (bph) in isfahan. materials and methods: in this study, 12...